Sector Spotlight: Crypto Surges, Healthcare Providers Retreat Amidst Market Shifts

New the Technical Analysis?: Learn more here about OBV (On Balance Volume), MACD and Bollinger Bands.

Today's market action saw a notable divergence among key sectors, with cryptocurrency-related assets leading the gainers, while healthcare providers experienced a significant downturn. We delve into the performance of the top three and bottom three sectors, highlighting those with movements exceeding 2%, and provide technical insights and relevant market context.

Top Performing Sectors

Crypto – Ethereum (ETHA)

The cryptocurrency sector, particularly Ethereum, demonstrated robust performance today, with the iShares Ethereum Trust (ETHA) surging by an impressive 4.14%. This strong move places it firmly at the top of today's sector leaderboard. The positive momentum comes as BlackRock's Ethereum ETF (ETHA) recently achieved a significant milestone, hitting $10 billion in assets under management in just one year, making it the third fastest ETF in history to reach this mark, following two Bitcoin ETFs. This indicates substantial institutional interest and capital rotation into Ethereum.

Technical analysis for ETHA paints a bullish picture, with a "Bullish Band Ride (Upper Band Support)" on its Bollinger Bands, suggesting sustained upward movement along the upper band [provided data]. While the On-Balance Volume (OBV) is "Approaching Bearish Crossover," indicating a potential shift in volume dynamics, the Moving Average Convergence Divergence (MACD) shows "Strong Bullish Momentum," reinforcing the current upward trend [provided data]. Ethereum's price has climbed over 65% in the past month and more than 160% since April, with the token trading around $3,771. Recent developments, such as the Ethereum Pectra upgrade going live on May 7, 2025, are designed to improve scalability and staking, further supporting the ecosystem's growth.

Uranium – Nuclear Power (URA)

The Uranium – Nuclear Power sector, represented by the Global X Uranium ETF (URA), showed strong gains, rising by 1.97% today. This sector continues to benefit from the growing global emphasis on clean energy and nuclear power expansion. The Global X Uranium ETF (URA) provides broad exposure to companies involved in uranium mining and nuclear component production.

Technically, URA is testing its "Upper Band Test (Resistance)" on the Bollinger Bands, suggesting it's approaching a key resistance level [provided data]. The On-Balance Volume (OBV) indicates an "Established Bullish Volume Trend," signaling consistent buying interest, and the MACD displays "Strong Bullish Momentum," aligning with the sector's positive performance [provided data]. The uranium sector is poised for significant growth, with reactor demand projected to nearly double by 2040, from an estimated 65,650 metric tonnes in 2023 to almost 130,000. The Global X Uranium ETF (URA) has already delivered an impressive 50.1% year-to-date return through July 2025.

Cannabis (MSOS)

The Cannabis sector, tracked by the AdvisorShares Pure US Cannabis ETF (MSOS), posted a gain of 1.45% today. This sector remains highly sensitive to regulatory developments and market sentiment regarding cannabis legalization. The AdvisorShares Pure US Cannabis ETF (MSOS) is noted as the largest Marijuana ETF by assets under management. Other notable ETFs in this space include the Roundhill Cannabis ETF (WEED) and the Cambria Cannabis ETF (TOKE).

From a technical perspective, MSOS is exhibiting a "Bullish Trend with Middle Band Support," indicating a healthy upward trajectory with the middle Bollinger Band acting as a support level [provided data]. However, the On-Balance Volume (OBV) shows "Bearish Divergence (Price Up, OBV Down)," which could be a cautionary signal suggesting that the recent price increase is not fully supported by buying volume [provided data]. Despite this, the MACD indicates "Accelerating Bullish Momentum," suggesting that short-term buying pressure is increasing [provided data]. The cannabis industry continues to see news of company expansions and ongoing discussions around legalization efforts.

Bottom Performing Sectors

Healthcare Providers (IHF)

The Healthcare Providers sector experienced a notable decline today, with the iShares U.S. Healthcare Providers ETF (IHF) falling by 2.75%. This significant drop makes it the worst-performing sector among those analyzed today, reflecting potential headwinds or profit-taking in the healthcare services space. The iShares U.S. Healthcare Providers ETF (IHF) aims to track U.S. equities within this specific healthcare segment.

Technical analysis for IHF points to a challenging outlook. The Bollinger Bands show a "Bearish Trend with Middle Band Resistance," indicating that the middle band is acting as a ceiling for price movements [provided data]. The On-Balance Volume (OBV) displays "Bearish Divergence (Price Up, OBV Down)," suggesting that the price is struggling to find sustained buying support [provided data]. The MACD is "General Bearish," reinforcing the negative sentiment [provided data]. The ETF has seen a negative performance over the last month and year, with its NAV total return down -10.50% year-to-date as of July 22, 2025. Recent reports mention a "UnitedHealth Plunge" dragging down healthcare ETFs, which could be contributing to the sector's weakness. Furthermore, IHF holds "sell signals" from both short and long-term moving averages and is considered oversold on RSI14.

Genomics (ARKG)

The Genomics sector, represented by ARK Genomic Revolution ETF (ARKG), saw a decline of 1.94% today, placing it among the bottom performers. Despite the day's dip, the broader genomics field is recognized for its long-term growth potential in revolutionizing healthcare. Other ETFs providing exposure to this innovative area include the Global X Genomics & Biotechnology ETF (GNOM) and the VanEck Genomics and Healthcare Innovators UCITS ETF (CURE, IDNA).

Interestingly, the technical analysis for ARKG presents a more optimistic view despite today's negative performance. The Bollinger Bands indicate a "Strong Bullish Trend (Outside Upper Band)," suggesting a powerful upward trajectory [provided data]. The On-Balance Volume (OBV) shows a "Strong Bullish Volume Trend (Consistent Accumulation)," implying significant buying interest, and the MACD signals "Strong Bullish Momentum" [provided data]. This divergence between today's price action and the technical indicators might suggest a short-term pullback within a larger bullish trend, or perhaps a re-evaluation of the sector by investors. Forecasts suggest that sales of genomic medicines could see a substantial compound annual growth rate from 2024-2030.

Metals & Mining (XME)

The Metals & Mining sector, tracked by the SPDR S&P Metals & Mining ETF (XME), experienced a decline of 1.62% today. This sector is highly sensitive to global economic growth, commodity prices, and industrial demand. The SPDR S&P Metals & Mining ETF (XME) is the largest ETF in this space by assets under management. It provides exposure to a diverse range of sub-industries including aluminum, coal, copper, gold, and steel.

Technically, XME is at an "Upper Band Test (Resistance)" on the Bollinger Bands, indicating it's facing resistance [provided data]. The On-Balance Volume (OBV) shows an "Established Bullish Volume Trend," suggesting underlying buying support, and the MACD indicates "Strong Bullish Momentum" [provided data]. Similar to Genomics, the bullish technicals contrast with today's negative price movement, potentially signaling a short-term correction. While the sector has seen some positive news regarding rare earths and tariff-induced shortages, recent reports also noted copper prices hitting a two-month low, which could be weighing on the sector. The ETF has shown a positive return over the past year, with a 23.97% total return including dividends.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top